ACRP blog

APRIL 5, 2023

The life sciences sector is increasingly leveraging technology across its operations, and this trend will continue in 2023 with more collaborations and partnerships between pharmaceutical, biotechnology, and medical device companies and information technology vendors, Lyons adds.

Big Data 52

Big Data Clinical Trials Clinical Trials Life Science 52

Roots Analysis

APRIL 4, 2023

In addition to the advances in processing power of computing machines and the development of smarter algorithms, big data is considered to be one of the key drivers of growth in this segment. Big data holds great promise in terms of its potential applications in the healthcare industry as mentioned below.

Big Data 52

Big Data Life Science Development Clinical Trials 52

Drug Discovery World

FEBRUARY 6, 2024

By making lab automation as easy as using a smartphone, the Flex robot democratises access to automation in life sciences research.” “For far too long, scientists have been constrained by their laboratory tools,” explains Jon Brennan-Badal, CEO of Opentrons. “By

Marketing 67

Marketing Medicine Genome Genomics 67

Pharma Marketing Network

SEPTEMBER 22, 2021

Panelists: Tim Glennon , Vice President of Marketing, Evofem Biosciences. Robert Schildt , Senior Director, Go-To-Market Innovation, Biohaven Pharmaceuticals. Marketing Agility – the Path to Digital Engagement & Innovation. Ray Gomez , Head, Worldwide Digital Marketing – Channel & Content Strategy, BD.

Big Data 52

Big Data Marketing Life Science Licensing 52

pharmaphorum

FEBRUARY 1, 2022

David Clifton is professor of clinical machine learning in the Department of Engineering Science of the University of Oxford. His research focuses on the development of big data machine learning for tracking the health of complex systems. Mark holds a PhD in biomedicine, and an MSc in biostatistics.

Clinical Trials 104

Clinical Trials Clinical Trials Trials Engineer 104

XTalks

APRIL 9, 2021

Content intelligence combines the powers of AI systems and software to process, mine and analyze data to gain insights into the effectiveness of content and help guide content strategies for businesses. The rapidly growing content intelligence market is expected to be worth over $2.6 billion by 2025.

Life Science 59

Life Science Big Data Compliance Marketing 59

Drug Discovery World

DECEMBER 20, 2022

As 2022 draws to a close, life sciences market analysts attempt to correctly predict what the next 12 months might bring to the drug discovery sector. DDW’s Diana Spencer summarises the key trends likely to impact the market in 2023. . In summary, 2023 could be a very exciting year for life sciences.

Drugs 52

Drugs Gene Editing Clinical Trials Clinical Trials 52

Pharma Marketing Network

SEPTEMBER 22, 2021

Panelists: Tim Glennon , Vice President of Marketing, Evofem Biosciences. Robert Schildt , Senior Director, Go-To-Market Innovation, Biohaven Pharmaceuticals. Marketing Agility – the Path to Digital Engagement & Innovation. Ray Gomez , Head, Worldwide Digital Marketing – Channel & Content Strategy, BD.

Big Data 40

Big Data Marketing Life Science Licensing 40

pharmaphorum

APRIL 8, 2022

Her research area is the secondary use of observational data of patients with rare and unclear diseases; with attention to the research data infrastructure and terminologies. The post Medical Informatics: a bridge between two worlds appeared first on.

Genome 78

Genome Genomics Research Big Data 78

pharmaphorum

FEBRUARY 11, 2022

In 2021, Komodo acquired two companies: Mavens, a developer of cloud-based software used for speciality biotech and pharma companies, and Breakaway Partners, a market access software company targeting the life sciences industry. He oversees operations, including business development, sales and marketing, and people.

Life Science 105

Life Science Engineer Development Big Data 105

pharmaphorum

OCTOBER 16, 2020

It enables careful collation and organisation of information, but the innovations of artificial intelligence (AI) are now taking things further, facilitating the effective analysis and interrogation of big data to create new treatment hypotheses. This percentage rose to 65% amongst QA, compliance, legal and regulatory professionals.

Clinical Trials 105

Clinical Trials Clinical Trials Trials Life Science 105

pharmaphorum

MAY 30, 2022

He oversees operations, including business development, sales and marketing, and people. He also serves as an executive advisor to Reify Health, Heads Up Health , and other healthcare/healthtech start-ups focused on big data, SaaS, healthcare IT (HIT), and predictive analytics to improve patient outcomes. About the author.

Clinical Trials 97

Clinical Trials Clinical Trials Trials Big Data 97

pharmaphorum

SEPTEMBER 18, 2020

German and Swiss pharma companies dominated the Swedish market at this time and it wasn’t until 1913 that the discussions were turned into a pharmaceutical company, Astra AB. Astra introduced two important product families onto the Swedish market in 1948: penicillin and anaesthetics, initially in the form of Xylocaine.

Pharma Companies 116

Pharma Companies Sales Vaccination Vaccine 116

pharmaphorum

JULY 4, 2022

Her research area is the secondary use of observational data of patients with rare and unclear diseases; with attention to the research data infrastructure and terminologies. In 2021, she co-founded OHDSI Germany, which is as a national node of the Observational Health Data Sciences and Informatics (OHDSI) Europe.

Genome 105

Genome Genomics Research Medicine 105

Drug Discovery World

SEPTEMBER 6, 2022

Indeed, the growth of the cell and gene therapy market, coupled with the demand that the pandemic placed on manufacturing capacity, means the industry faces shortages of these crucial materials. The challenge for the market then, according to Boissel, is how much can a payor afford to pay upfront? . But challenges remain.

Gene Therapy 52

Gene Therapy Gene Manufacturing Medicine 52

XTalks

AUGUST 2, 2023

Join us as we present an in-depth analysis of each company’s revenue, net income, R&D investments, core therapeutic areas, market presence and strategic collaborations. is a global pharmaceutical company, working across both developed and emerging markets. 2022 Revenue: Pfizer reported an annual revenue of $100.33 Pfizer Inc.

Sales 98

Sales Manufacturing FDA Approval Life Science 98

Pharmaceutical Technology

JUNE 20, 2023

The current tech landscape is rapidly evolving, with advancements in areas such as big data and conversational platforms. Most of us have heard of ChatGPT and AI but where and how do they fit into the life sciences ecosystem? Neural networks learn to “translate” from language A to language B.

Life Science 130

Life Science Clinical Trials Clinical Trials Regulation 130

Pharmaceutical Technology

JANUARY 11, 2023

The global market size is estimated to be more than $95.3bn 1. Services such as Personal Health Records and diagnostic apps collect, store and analyse patient data, which assists healthcare practitioners with diagnosis as well as enabling them to create tailored treatment plans based on the needs of the patient. Free Whitepaper.

Life Science 130

Life Science Engineer Doctors Doctor 130